High blood pressure during targeted cancer therapy calls for regular readings, a medication record, and clear instructions about when to call. Your cancer team can often treat the rise while continuing your cancer treatment.
Facing a life-threatening disease already asks much of you. Another number can feel like another burden, but a simple routine can help you share that burden with your care team.
Begin with what you can measure, what you notice, and what needs attention.
Key Takeaways for Your Next Visit
- Record both blood pressure numbers, your pulse, symptoms, and medication timing.
- Ask your oncology team for a home-checking schedule, a treatment goal, and same-day calling thresholds.
- Seek emergency help for chest pain, severe breathlessness, sudden weakness, confusion, or sudden vision changes.
- Don’t change cancer medicines or blood pressure doses without instructions.
Why Can Targeted Therapy Cause Hypertension?
Hypertension means persistently high blood pressure. Some targeted medicines interfere with signals that help blood vessels relax. When vessels tighten, pressure rises.
Medicines that block vascular endothelial growth factor, or VEGF, deserve particular attention. This protein helps blood vessels grow. Bevacizumab (Avastin), axitinib (Inlyta), lenvatinib (Lenvima), and sunitinib (Sutent) affect this pathway.
Pressure can rise early, even when you feel well. Pain, steroids, kidney problems, and existing hypertension can also contribute.
Different drugs need different monitoring. The FDA’s Avastin prescribing information calls for blood pressure checks every two to three weeks during treatment. Lenvatinib instructions call for checks after one week, every two weeks for two months, then at least monthly. Your team may add more frequent home readings.
How Should You Track Blood Pressure at Home?
Make each reading dependable
Choose a validated upper-arm monitor with a cuff that fits. Bring it to an appointment so your team can compare readings.
Avoid caffeine, smoking, and exercise for 30 minutes beforehand. Empty your bladder. Sit for five minutes with your back supported, feet flat, and legs uncrossed. Rest your arm at heart level, with the cuff against bare skin.
Don’t talk during the measurement. The American Heart Association’s home-monitoring guidance recommends two readings, one minute apart.
Give the numbers a little context
Record both readings rather than keeping only the lower one. Add the date, time, pulse, symptoms, and timing of cancer and blood pressure medicines.
Use your Cancer Fighter’s Journal, a notebook, or a phone note. A smartwatch doesn’t replace a validated cuff unless its blood pressure function meets appropriate validation standards.
Example entry (fictional): May 14, 2025, 8 a.m. | 128/78 and 126/76 mm Hg, one minute apart | pulse 72 | no symptoms | cancer medicine: imatinib, 7 a.m.; pressure medicine: amlodipine, 7 a.m.
Ask about daily checks when treatment begins or doses change. Agree on who reviews your readings and how you should send them. A portal entry doesn’t guarantee an immediate response.
Which Numbers Need Attention?
The top number, systolic pressure, measures pressure when your heart beats. The bottom number, diastolic pressure, measures pressure between beats.
These adult categories help you understand a reading.
| Category | Systolic, mm Hg | Diastolic, mm Hg |
|---|---|---|
| Normal | Below 120 | Below 80 |
| Elevated | 120 to 129 | Below 80 |
| Stage 1 hypertension | 130 to 139 | 80 to 89 |
| Stage 2 hypertension | 140 or higher | 90 or higher |
Except for normal and elevated readings, either number can place you in the higher category. One reading alone doesn’t establish a diagnosis.
The 2025 AHA/ACC guideline summary gives a general blood pressure target below 130/80. Your oncology team may choose another goal because of dizziness, frailty, kidney function, or treatment needs.
Contact your team the same day for repeated readings at or above 160 systolic or 100 diastolic, unless your plan sets a lower threshold.
If either number exceeds 180 systolic or 120 diastolic without symptoms, wait at least one minute and repeat. If it remains that high, contact a clinician immediately.
With chest pain, severe breathlessness, sudden weakness, confusion, or sudden vision changes, call emergency services. Don’t delay for another measurement, regardless of the number.
What Else Belongs in Your Journal?
Numbers tell only part of the story. Record headaches, swelling, changes in urination, vomiting, diarrhea, and trouble drinking. Include missed doses without embarrassment. Your team needs an accurate picture, not a perfect record.
Note dizziness during cancer treatment, especially when standing. Parkinson’s disease and some medicines for it can also cause pressure to fall on standing.
Your clinicians may order kidney-function tests, blood potassium measurements, and urine tests for protein. VEGF-blocking treatments can affect the kidneys, and blood pressure medicines can change potassium levels.
Keep the dates of blood tests and medication changes beside your readings. Continue the agreed monitoring during treatment breaks and remission. Pressure may fall after your team pauses or stops a pressure-raising cancer drug, so your blood pressure prescription may need adjustment.
Which Medicines Can Help During Cancer Treatment?
Match the medicine to your health
The 2025 guideline recommends three types of antihypertensive drugs, or medicines that lower pressure. They include thiazide-type diuretics, long-acting dihydropyridine calcium channel blockers, and ACE inhibitors or angiotensin receptor blockers (ARBs). These medicines help prevent heart disease and stroke.
Their everyday effects differ.
| Drug class and example | How it works | Important cautions |
|---|---|---|
| ACE inhibitor, lisinopril; ARB, losartan | Relaxes blood vessels | Potassium and kidney changes; ACE inhibitors can cause cough |
| Long-acting calcium channel blocker, amlodipine | Relaxes artery walls | Ankle swelling, flushing, headache |
| Thiazide-type diuretic, chlorthalidone | Helps kidneys remove salt and water | Dehydration, low sodium or potassium, gout |
ACE inhibitors or ARBs may suit patients with protein in their urine. Clinicians generally avoid combining these two classes.
An oncology pharmacist should review cancer medication interactions. Diltiazem and verapamil, different calcium channel blockers, can interact with some oral targeted drugs. Beta blockers may help when another heart condition supports their use.
When two medicines make sense
For stage 2 hypertension, the 2025 guideline announcement recommends combination therapy with two medicines, preferably in one pill.
The supporting evidence advanced from expert opinion, labeled C-EO in 2017, to randomized-trial evidence, labeled B-R in 2025.
Fewer than one-third of U.S. adults with hypertension use single-pill combinations. Fewer pills simplify the schedule and may support medication adherence, helping people take medicines as prescribed. Studies associate these combinations with better blood pressure control.
How Much Can One or Two Medicines Lower Pressure?
A meta-analysis of 484 placebo-controlled trials involving 104,176 participants found that one standard-dose medicine lowered systolic blood pressure by 8.7 mm Hg. Its 95% confidence interval, an uncertainty range around the estimate, ran from 8.2 to 9.2. A randomized controlled trial is a study that assigns participants by chance.
Doubling one medicine’s dose added only about 1.5 mm Hg of reduction. Two medicines, each at a standard dose, lowered systolic pressure by 14.9 mm Hg, with a confidence interval of 13.1 to 16.8.
Using a starting systolic pressure of 154 mm Hg, researchers grouped regimens by expected reduction: low intensity meant under 10 mm Hg, moderate meant 10 to 19, and high meant 20 or more.
Among 57 standard-dose monotherapies, meaning treatments with one medicine, 45 (79%) fell into the low-intensity group. Among 189 two-drug combinations, 110 (58%) fell into the moderate group and 21 (11%) into the high group.
These averages come from general hypertension studies, not targeted cancer therapy alone. They help explain why adding a different medicine may accomplish more than repeatedly increasing one dose.
How Do Other Conditions Change the Plan?
Your medical history matters more than a standard prescription.
The Diuretic Comparison Project randomized 13,523 older adults taking hydrochlorothiazide, commonly 25 mg daily, to continue it or switch to chlorthalidone. Switching didn’t reduce cardiovascular events. Neither medicine automatically fits every patient.
The 2025 guideline also removed race-based initial drug selection. The 2017 guidance had preferred a thiazide or calcium channel blocker over an ACE inhibitor or ARB for Black adults without heart failure or chronic kidney disease.
For some adults at increased cardiovascular risk, clinicians may pursue systolic pressure below 120 when appropriate and tolerated. A person’s cardiovascular risk, cancer treatment, and ability to tolerate that goal all help determine whether it fits. Cancer treatment doesn’t automatically make that the goal.
Pregnancy needs a separate plan and immediate coordination with oncology. The pregnancy goal is below 140/90. Extended-release nifedipine and labetalol are first choices; methyldopa and hydrochlorothiazide are alternatives. ACE inhibitors and ARBs can harm the developing baby, so clinicians avoid them during pregnancy.
Questions You May Carry Into Your Appointment
Why does pressure stay high despite treatment?
Resistant hypertension means pressure stays above goal despite three appropriate medicines, usually including a diuretic. Missed doses, excess sodium, interacting medicines, kidney disease, and sleep apnea can contribute. Primary aldosteronism, a condition in which the body makes too much aldosterone, can also play a role. Your team should investigate rather than assume you need another pill.
Could a six-month injection replace daily tablets?
Zilebesiran remains an investigational option. In KARDIA-1, involving 394 adults with mild-to-moderate hypertension, it lowered 24-hour systolic pressure by more than 10 mm Hg versus placebo during six months. It reduces production of angiotensinogen, a protein involved in pressure regulation. That trial doesn’t establish it as routine care for cancer-treatment hypertension.
Will high pressure mean stopping cancer treatment?
Not necessarily. Your oncologist may add blood pressure treatment, adjust doses, or temporarily pause the cancer medicine. Severe uncontrolled pressure can require a pause; a blood pressure emergency can require permanent discontinuation of certain drugs.
Let the Record Carry Some of the Weight
A few dependable readings and an honest symptom record can help your team protect your heart while treating your cancer. You don’t have to interpret every change alone.
Keep your written action plan beside your monitor, including after-hours numbers. There is courage in making that call, even when you’re unsure what the numbers mean.
